What's new

Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 5, Status: Authorised

Jun 11, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Women, young adults, and Native people hit hard by rapid increase in alcohol liv...

Next Article

Human medicines European public assessment report (EPAR): Leflunomide Zentiva (p...

Related Posts

Training session on Human variations web-based electronic Application Form (eAF) for non-CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 1 July 2025, 10:00 (CEST) to 1 July 2025, 11:30 (CEST)

Training session on Human variations web-based electron...

Jun 10, 2025  0

EMEA-003434-PIP02-23

EMEA-003434-PIP02-23

Jun 10, 2025  0

EMEA-002042-PIP03-23

EMEA-002042-PIP03-23

Jun 6, 2025  0